Skip to main content

Current management and controversies

A Radiotherapist’s View

  • Chapter
Book cover Hodgkin’s Disease in Children

Part of the book series: Cancer Treatment and Research ((CTAR,volume 41))

  • 36 Accesses

Abstract

The goal in managing patients with Hodgkin’s disease is cure of the disease with minimal morbidity, yet maximal quality of life. This goal is universal; it does not represent a controversy. The issues over which there rest divided opinions relate to therapeutic orientation on how to achieve this goal and are largely issues of staging, treatment, and follow-up. Some controversies arise because of facilities available, individual expertise, or experience. Today a child with Hodgkin’s disease has an ~90% likelihood of cure following accurate staging and treatment in a center with demonstrated expertise in pediatric Hodgkin’s disease [1]. Such gratifying results require individualization of therapy, as no two cases of the disease are identical. The management of children requires utilization of not only principles that apply to the adult population, but also judgment with respect to age, stage, and extent of disease, tumor burden, therapeutic options, and late effects of treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Donaldson SS: Hodgkin’s disease. In: Voute PA, Barrett A, Bloom HJG, Lemerle J, Neidhardt MK (eds) Cancer in children: clinical management, 2nd edn. Berlin: Springer, 1986, pp 164–175.

    Google Scholar 

  2. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the Committee on Hodgkin’s Disease Staging. Cancer Res 31:1860–1861, 1971.

    PubMed  CAS  Google Scholar 

  3. Musshoff K, Boutis L: Therapy results in Hodgkin’s disease. Freiburg i. Br., 1948–1966. Cancer 21:1100–1113, 1968.

    Article  PubMed  CAS  Google Scholar 

  4. Musshoff K: Therapy and prognosis of two different forms of organ involvement in cases of malignant lymphoma (Hodgkin’s disease, reticulum cell sarcoma, lymphosarcoma) as well as a report about stage division in these diseases. Klin Wochenschr 48:673–678, 1970.

    Article  PubMed  CAS  Google Scholar 

  5. Kaplan HS: Hodgkin’s disease, 2nd edn. Cambridge: Harvard University, 1980.

    Google Scholar 

  6. Levi JA, Wiernik PH: Limited extranodal Hodgkin’s disease: unfavorable prognoses and therapeutic implications. Am J Med 63:365–372, 1977.

    Article  PubMed  CAS  Google Scholar 

  7. Torti FM, Portlock CS, Rosenberg SA, Kaplan HS: Extralymphatic Hodgkin’s disease: prognosis and response to therapy. Am J Med 70:487–492, 1981.

    Article  PubMed  CAS  Google Scholar 

  8. Lee CKK, Bloomfield CD, Goldman AI, Nesbit ME, Levitt SH: The therapeutic utility of lung irradiation for Hodgkin’s disease patients with large mediastinal masses. Int J Radiat Oncol Biol Phys 7:151–154, 1981.

    Article  PubMed  CAS  Google Scholar 

  9. Hagemeister FB, Fuller LM, Velasquez WS, et al.: Stage I and II Hodgkin’s disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP. Cancer Treat Rep 66:789–798, 1982.

    PubMed  CAS  Google Scholar 

  10. Hoppe RT, Coleman CN, Cox PS, Rosenberg SA, Kaplan HS: The management of stage I-II Hodgkin’s disease with irradiation alone or combined modality therapy: the Stanford experience. Blood 59:455–465, 1982.

    PubMed  CAS  Google Scholar 

  11. Mauch P, Gorshein D, Cunningham J, Hellman S: Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin’s disease. Cancer Treat Rep 66:809–818, 1982.

    PubMed  CAS  Google Scholar 

  12. Thar TL, Million RR, Hausner RJ, McKetty MHB: Hodgkin’s disease, stage I and II: relationship of recurrence to size of disease, radiation dose, and number of sites involved. Cancer 43:1101–1105, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Velentjas E, Barrett A, McElwain TJ, Peckham MJ: Mediastinal involvement in early-stage Hodgkin’s disease: response to treatment and pattern of relapse. Eur J Cancer 16:1065–1068, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Castellino RA, Blank N, Hoppe RT, Cho C: Hodgkin’s disease: contributions of chest CT in the initial staging evaluation. Radiology 160:603–605, 1986.

    PubMed  CAS  Google Scholar 

  15. Meyer JE, Linggood RM, Lindfors KK, McLoud TC, Stomper PC: Impact of thoracic computed tomography on radiation therapy planning in Hodgkin’s disease. J Comput Assist Tomogr 8:892–894, 1984.

    Article  PubMed  CAS  Google Scholar 

  16. Rostock RA, Siegelman SS, Lenhard RE, Wharam MD, Order SE: Thoracic CT scanning for mediastinal Hodgkin’s disease: results and therapeutic implications. Int J Radiat Oncol Biol Phys 9:1451–1457, 1983.

    PubMed  CAS  Google Scholar 

  17. Robinson B, Kingston J, Nogueira Costa R, Malpas JS, Barrett A, McElwain TJ: Chemotherapy and irradiation in childhood Hodgkin’s disease. Arch Dis Child 59:1162–1167, 1984.

    Article  PubMed  CAS  Google Scholar 

  18. Bonadonna G, Valagussa P, Santoro A: Prognosis of bulky Hodgkin’s disease treated with chemotherapy alone or combined with radiotherapy. Cancer Surv 4:439–458, 1985.

    PubMed  CAS  Google Scholar 

  19. Lister TA, Dorreen MS, Faux M, Jones AE, Wrigley PFM: The treatment of stage III-A Hodgkin’s disease. J Clin Oncol 1:745–749, 1983.

    PubMed  CAS  Google Scholar 

  20. Prosnitz LR, Cooper D, Cox EB, Kapp DS, Farber LR: Treatment selection for stage III-A Hodgkin’s disease patients. Int J Radiat Oncol Biol Phys 11:1431–1437, 1985.

    Article  PubMed  CAS  Google Scholar 

  21. Desser RK, Golomb HM, Ultmann JE, et al.: Prognostic classification of Hodgkin’s disease in pathologic stage III based on anatomic considerations. Blood 49:883–893, 1977.

    PubMed  CAS  Google Scholar 

  22. Hoppe RT, Rosenberg SA, Kaplan HS, Cox RS: Prognostic factors in pathological stage III-A Hodgkin’s disease. Cancer 46:1240–1246, 1980.

    Article  PubMed  CAS  Google Scholar 

  23. Hoppe RT, Cox RS, Rosenberg SA, Kaplan HS: Prognostic factors in pathologic stage III Hodgkin’s disease. Cancer Treat Rep 66:743–749, 1982.

    PubMed  CAS  Google Scholar 

  24. Dunnick NR, Parker BR, Castellino RA: Pediatric lymphography: performance, interpretation and accuracy in 193 consecutive children. Am J Radiol 129:639–645, 1977.

    CAS  Google Scholar 

  25. Castellino RA, Bellani FF, Gasparini M, Terno G, Musumeci R: Lymphography in childhood: six years experience with 242 cases. Lymphology 8:74–83, 1975.

    PubMed  CAS  Google Scholar 

  26. Daneman A, Martin DJ, Fitz CR, Chan HSL: Computed tomography and lymphogram correlation in children with Hodgkin’s disease. J Comput Assist Tomogr 7:115–122, 1983.

    CAS  Google Scholar 

  27. Castellino RA, Marglin SI: Imaging of abdominal and pelvic lymph nodes: lymphography or computed tomography? Invest Radiol 17:433–443, 1982.

    Article  PubMed  CAS  Google Scholar 

  28. Parker BR, Castellino RA, Kaplan HS: Pediatric Hodgkin’s disease. I. Radiographic evaluation. Cancer 37:2430–2435, 1976.

    Article  PubMed  CAS  Google Scholar 

  29. Castellino RA, Hoppe RT, Blank N, et al.: Computed tomography, lymphography, and Staging laparotomy: correlations in initial staging of Hodgkin’s disease. Am J Radiol 143:37–41, 1984.

    CAS  Google Scholar 

  30. Green DM, Ghoorah J, Douglass HO, et al.: Staging laparotomy with splenectomy in children and adolescents with Hodgkin’s disease. Cancer Treat Rev 10:23–38, 1983.

    Article  PubMed  CAS  Google Scholar 

  31. Wilimas J, Thompson E, Smith KL: Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin’s disease. Cancer 42:1929–1935, 1978.

    Article  PubMed  CAS  Google Scholar 

  32. Mauch P, Goodman R, Hellman S: The significance of mediastinal involvement in early stage Hodgkin’s disease. Cancer 42:1039–1045, 1978.

    Article  PubMed  CAS  Google Scholar 

  33. Schomberg PJ, Evans RG, O’Connell MJ, et al.: Prognostic significance of mediastinal mass in adult Hodgkin’s disease. Cancer 53:324–328, 1984.

    Article  PubMed  CAS  Google Scholar 

  34. Donaldson SS, Link MP: Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin’s disease. 1987 (in press).

    Google Scholar 

  35. Ray GR, Trueblood HW, Enright LP, Kaplan HS, Nelsen TS: Oophoropexy: a means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin’s disease. Radiology 96:175–180, 1970.

    PubMed  CAS  Google Scholar 

  36. Donaldson SS, Glatstein E, Rosenberg SA, Kaplan HS: Pediatric Hodgkin’s disease. II. Results of therapy. Cancer 37:2436–2447, 1976.

    Article  PubMed  CAS  Google Scholar 

  37. Botnick LE, Goodman R, Jaffe N, Filler R, Cassady JR: Stages I-III Hodgkin’s disease in children: results of staging and treatment. Cancer 39:599–603, 1977.

    Article  PubMed  CAS  Google Scholar 

  38. Dearth JC, Gilchrist GS, Burgert EO, Telander RL, Cupps RE: Management of stages I to III Hodgkin’s disease in children. J Pediatr 96:829–836, 1980.

    Article  PubMed  CAS  Google Scholar 

  39. Russell KR, Donaldson SS, Cox RS, Kaplan HS: Childhood Hodgkin’s disease: patterns of relapse. J Clin Oncol 2:80–87, 1984.

    PubMed  CAS  Google Scholar 

  40. Boles ET, Haase GM, Hamoudi AB: Partial splenectomy in staging laparotomy for Hodgkin’s disease: an alternative approach. J Pediatr Surg 13:581–586, 1978.

    Article  PubMed  Google Scholar 

  41. Dearth JC, Gilchrist GS, Telander RL, O’Connell MJ, Weiland LH: Partial splenectomy for staging Hodgkin’s disease: risk of false-negative results. N Engl J Med 299:345–346, 1978.

    Article  PubMed  CAS  Google Scholar 

  42. Jereb B, Tan C, Bretsky S, He S, Exelby P: Involved field (IF) irradiation with or without chemotherapy in the management of children with Hodgkin’s disease. Med Pediatr Oncol 12:325–332, 1984.

    Article  PubMed  CAS  Google Scholar 

  43. Cramer P, Andrieu J: Hodgkin’s disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB. J Clin Oncol 3:1495–1502, 1985.

    PubMed  CAS  Google Scholar 

  44. Bayle-Weisgerber C, Lemercier N, Teillet F, Asselain B, Gout M, Schweisguth O: Hodgkin’s disease in children: results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years. Cancer 54:215–222, 1984.

    Article  PubMed  CAS  Google Scholar 

  45. Jenkin D, Chan H, Freedman M, et al.: Hodgkin’s disease in children: treatment results with MOPP and low-dose, extended-field irradiation. Cancer Treat Rep 66:949–959, 1982.

    PubMed  CAS  Google Scholar 

  46. Andrieu J, Desprez-Curely J, Jacquillat C, Weil M: MOPP chemotherapy plus irradiation for Hodgkin’s disease, stage I-A to III-B: long-term results of the prospective trial H72 (1972–1976, 334 patients). Hematol Oncol 3:219–231, 1985.

    Article  PubMed  CAS  Google Scholar 

  47. Donaldson SS, Kaplan HS: Complications of treatment of Hodgkin’s disease in children. Cancer Treat Rep 66:977–989, 1982.

    PubMed  CAS  Google Scholar 

  48. Desser RK, Ultmann JE: Risk of severe infection in patients with Hodgkin’s disease or lymphoma after diagnostic laparotomy and splenectomy. Ann Intern Med 77:143–146, 1972.

    PubMed  CAS  Google Scholar 

  49. Rosenstock JG, D’Angio GJ, Kiesewetter WB: The incidence of complications following staging laparotomy for Hodgkin’s disease in children. Radiology 120:531–535, 1974.

    CAS  Google Scholar 

  50. Chilcote RR, Baehner RL, Hammond D, and Children’s Cancer Study Group: Septicemia and meningitis in children splenectomized for Hodgkin’s disease. N Engl J Med 295:798–800, 1976.

    Article  Google Scholar 

  51. Donaldson SS, Glatstein E, Vosti KL: Bacterial infections in pediatric Hodgkin’s disease: relationship to radiotherapy, chemotherapy and splenectomy. Cancer 41:1949–1958, 1978.

    Article  PubMed  CAS  Google Scholar 

  52. Weitzman S, Aisenberg AC: Fulminant sepsis after the successful treatment of Hodgkin’s disease. Am J Med 62:47–50, 1977.

    Article  PubMed  CAS  Google Scholar 

  53. Dailey MO, Coleman CN, Kaplan HS: Radiation-induced splenic atrophy in patients with Hodgkin’s disease and non-Hodgkin’s lymphomas. N Engl J Med 302:215–217, 1980.

    Article  PubMed  CAS  Google Scholar 

  54. Coleman CN, McDougall IR, Dailey MO, Ager P, Bush S, Kaplan HS: Functional hyposplenia after splenic irradiation for Hodgkin’s disease. Ann Intern Med 96:44–47, 1982.

    PubMed  CAS  Google Scholar 

  55. Siber GR, Weitzman SA, Aisenberg AC, Weinstein HJ, Schiffman G: Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin’s disease. N Engl J Med 299:442–448, 1978.

    Article  PubMed  CAS  Google Scholar 

  56. Donaldson SS, Vosti KL, Berberich FR, Cox RS, Kaplan HS, Schiffman G: Response to pneumococcal vaccine among children with Hodgkin’s disease. Rev Infect Dis [Suppl] 3:S133-S143, 1981.

    Article  PubMed  Google Scholar 

  57. Russell KJ, Hoppe RT, Colby TV, Burns BF, Cox RS, Kaplan HS: Lymphocyte predominant Hodgkin’s disease: clinical presentation and results of treatment. Radiother Oncol 1:197–205, 1984.

    Article  PubMed  CAS  Google Scholar 

  58. Jacobs P, King HS, Karabus C, Hartley P, Werner D: Hodgkin’s disease in children: a ten-year experience in South Africa. Cancer 53:210–213, 1984.

    Article  PubMed  CAS  Google Scholar 

  59. Ekert H, Waters KD: Results of treatment of 18 children with MOPP chemotherapy as the only treatment modality. Med Pediatr Oncol 11:322–326, 1983.

    Article  PubMed  CAS  Google Scholar 

  60. Olweny CLM, Katongole-Mbidde E, Kiire C, Lwanga SK, Magrath I, Ziegler JL: Childhood Hodgkin’s disease in Uganda: a ten-year experience. Cancer 42:787–792, 1978.

    Article  PubMed  CAS  Google Scholar 

  61. Probert JC, Parker BR, Kaplan HS: Growth retardation in children after megavoltage irradiation of the spine. Cancer 32:634–639, 1973.

    Article  PubMed  CAS  Google Scholar 

  62. Kaplan HS, Rosenberg SA: The treatment of Hodgkin’s disease. Med Clin North Am 50:1591–1610, 1966.

    PubMed  CAS  Google Scholar 

  63. De Vita VT, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73:881–895, 1970.

    Google Scholar 

  64. Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C: Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imadazole carbox-amide versus MOPP. Cancer 36:252–259, 1975.

    Article  PubMed  CAS  Google Scholar 

  65. Valagussa P, Santoro A, Fossati Bellani F, Franchi F, Banfi A, Bonadonna G: Absence of treatment-induced second neoplasms after ABVD in Hodgkin’s disease. Blood 59:488–494, 1982.

    PubMed  CAS  Google Scholar 

  66. Mauch PM, Weinstein H, Botnick L, Belli J, Cassady JR: An evaluation of long-term survival and treatment complications in children with Hodgkin’s disease. Cancer 51:925–932, 1983.

    Article  PubMed  CAS  Google Scholar 

  67. Wilimas J, Thompson E, Smith KL: Long-term results of treatment of children and adolescents with Hodgkin’s disease. Cancer 46:2123–2125, 1980.

    Article  PubMed  CAS  Google Scholar 

  68. Herman TS, Hoppe RT, Donaldson SS, Cox RS, Rosenberg SA, Kaplan HS: Late relapse among patients treated for Hodgkin’s disease. Ann Intern Med 102:292–297, 1985.

    PubMed  CAS  Google Scholar 

  69. Constine LS, Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS: Thyroid dysfunction after radiotherapy in children with Hodgkin’s disease. Cancer 53:878–883, 1984.

    Article  PubMed  CAS  Google Scholar 

  70. McDougall IR, Coleman CN, Burke JS, Saunders W, Kaplan HS: Thyroid carcinoma after high-dose external radiotherapy for Hodgkin’s disease: report of three cases. Cancer 45: 2056–2060, 1980.

    Article  PubMed  CAS  Google Scholar 

  71. Jochelson M, Mauch P, Balikian J, Rosenthal D, Canellos G: The significance of the residual mediastinal mass in treated Hodgkin’s disease. J Clin Oncol 3:637–640, 1985.

    PubMed  CAS  Google Scholar 

  72. Jochelson MS, Tarbeil NJ, Weinstein HJ: Unusual thoracic radiologic findings in children treated for Hodgkin’s disease. J Clin Oncol 4:874–882, 1986.

    PubMed  CAS  Google Scholar 

  73. Castellino RA, Bergiron C, Markovits P: Repeat lymphography in children with Hodgkin’s disease. Cancer 38:90–95, 1976.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Donaldson, S.S. (1989). Current management and controversies. In: Kamps, W.A., Humphrey, G.B., Poppema, S. (eds) Hodgkin’s Disease in Children. Cancer Treatment and Research, vol 41. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1739-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1739-5_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8978-4

  • Online ISBN: 978-1-4613-1739-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics